Yabao Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Yabao Pharmaceutical Group has a total shareholder equity of CN¥3.1B and total debt of CN¥245.0M, which brings its debt-to-equity ratio to 8%. Its total assets and total liabilities are CN¥4.0B and CN¥891.1M respectively. Yabao Pharmaceutical Group's EBIT is CN¥276.6M making its interest coverage ratio 27.8. It has cash and short-term investments of CN¥589.5M.
Key information
8.0%
Debt to equity ratio
CN¥245.05m
Debt
Interest coverage ratio | 27.8x |
Cash | CN¥589.45m |
Equity | CN¥3.08b |
Total liabilities | CN¥891.06m |
Total assets | CN¥3.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600351's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥814.7M).
Long Term Liabilities: 600351's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥76.4M).
Debt to Equity History and Analysis
Debt Level: 600351 has more cash than its total debt.
Reducing Debt: 600351's debt to equity ratio has reduced from 30.2% to 8% over the past 5 years.
Debt Coverage: 600351's debt is well covered by operating cash flow (227.4%).
Interest Coverage: 600351's interest payments on its debt are well covered by EBIT (27.8x coverage).